跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
lariderm 3 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
lariderm 3
Approved
STANDARD
lariderm 3
Jirah Manufacturing Corporation.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
29efe3a740b29d56
Company
Jirah Manufacturing Corporation.
Type
Standard
Approval Details
Approval Id
29efe3a740b29d56
Drug Approval Philippines Name
lariderm 3
Product Name
lariderm 3
Registration Number
DRHR-837
Brand Name
lariderm 3
Generic Name
Tretinoin+Hydroquinone
Dosage Form
Topical Solution
Dosage Strength
24 mg (0.25%) / 2 g (2.0 % w/v) per 100 mL
Manufacturer
Jirah Manufacturing Corporation.
Issuance Date
25 February 2025
Expiry Date
24 July 2029
Pharmacologic Category
Drug
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
29efe3a740b29d56
Type
Standard
Back to Philippines FDA Approvals